PATENT CLAIM ANALYSIS

Application Number: 15902770
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "226500"]

Abstract:
Disclosed herein are compositions comprising an NSAID such as meloxicam in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of conditions such as pain.

Claim (Index 21):
The method of  claim 16 , wherein the solid dosage form contains about 100 mg of the SBE\u03b2CD.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.35135
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15132130', '15797955', '11287888', '14996985', '14522921']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7262267373547657
- 35 USC 102 Novelty (BERT): 0.5555689945449799
- Combined Prediction Score: 0.7091609630737872
- Mean Citation Score: 259.02999
- Max Citation Score: 415.5784
- Similarity Product: 285.8991977149963

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test